Attached files

file filename
10-Q - FORM 10-Q - HELIX BIOMEDIX INCd10q.htm
EX-31.2 - SECTION 302 CFO CERTIFICATION - HELIX BIOMEDIX INCdex312.htm
EX-32.1 - SECTION 906 CEO CERTIFICATION - HELIX BIOMEDIX INCdex321.htm
EX-31.1 - SECTION 302 CEO CERTIFICATION - HELIX BIOMEDIX INCdex311.htm
EX-10.20 - AMENDMENT - HELIX BIOMEDIX INCdex1020.htm
EX-10.10(C) - THIRD AMENDMENT TO LEASE - HELIX BIOMEDIX INCdex1010c.htm

Exhibit 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350

I, R. Stephen Beatty, Acting Chief Financial Officer of Helix BioMedix, Inc. (the “Company”), certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) the Quarterly Report on Form 10-Q of the Company for the quarterly period ended September 30, 2009 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 5, 2009

 

/s/    R. Stephen Beatty

R. Stephen Beatty

Acting Chief Financial Officer